Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Correction to "NMR Assays for Estimating the O-Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation".

Martini S, Aggravi M, Cianetti S, Egan W, Meppen M, Moriconi A, Simeone L, Berti F.

ACS Omega. 2019 Sep 10;4(13):15771. doi: 10.1021/acsomega.9b02774. eCollection 2019 Sep 24.

2.

NMR Assays for Estimating the O-Acetyl Content of Meningococcal Polysaccharide Serogroup A in Quadrivalent Conjugate Vaccine Formulation.

Martini S, Aggravi M, Cianetti S, Egan W, Meppen M, Moriconi A, Simeone L, Berti F.

ACS Omega. 2019 Jul 29;4(7):12827-12832. doi: 10.1021/acsomega.9b01678. eCollection 2019 Jul 31. Erratum in: ACS Omega. 2019 Sep 10;4(13):15771.

3.

Minimal physical therapy utilization compared with higher physical therapy utilization for patients with low back pain: a systematic review.

Ojha H, Masaracchio M, Johnston M, Howard RJ, Egan WE, Kirker K, Davenport TE.

Physiother Theory Pract. 2019 Feb 9:1-22. doi: 10.1080/09593985.2019.1571135. [Epub ahead of print]

PMID:
30739564
4.

Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.

Khan AS, Benetti L, Blumel J, Deforce D, Egan WM, Knezevic I, Krause PR, Mallet L, Mayer D, Minor PD, Neels P, Wang G.

Biologicals. 2018 Sep;55:1-16. doi: 10.1016/j.biologicals.2018.08.002. Epub 2018 Aug 6.

PMID:
30093175
5.

Vitamin B12 deficiency-induced neuropathy secondary to prolonged recreational use of nitrous oxide.

Egan W, Steinberg E, Rose J.

Am J Emerg Med. 2018 Sep;36(9):1717.e1-1717.e2. doi: 10.1016/j.ajem.2018.05.029. Epub 2018 May 24.

PMID:
29859645
6.

Implications of Dynamic Occupancy, Binding Kinetics, and Channel Gating Kinetics for hERG Blocker Safety Assessment and Mitigation.

Pearlstein RA, MacCannell KA, Erdemli G, Yeola S, Helmlinger G, Hu QY, Farid R, Egan W, Whitebread S, Springer C, Beck J, Wang HR, Maciejewski M, Urban L, Duca JS.

Curr Top Med Chem. 2016;16(16):1792-818. Review.

PMID:
26975508
7.

Timing of Physical Therapy Initiation for Nonsurgical Management of Musculoskeletal Disorders and Effects on Patient Outcomes: A Systematic Review.

Ojha HA, Wyrsta NJ, Davenport TE, Egan WE, Gellhorn AC.

J Orthop Sports Phys Ther. 2016 Feb;46(2):56-70. doi: 10.2519/jospt.2016.6138. Epub 2016 Jan 11. Review.

PMID:
26755406
8.

The addition of manipulation to an extension-oriented intervention for a patient with chronic LBP.

Ojha H, Egan W, Crane P.

J Man Manip Ther. 2013 Feb;21(1):40-7. doi: 10.1179/2042618612Y.0000000014.

9.

Letter to the editor: response.

Burns SA, Egan W, Glynn P, Cleland J.

Sports Health. 2012 Jan;4(1):16. No abstract available.

10.
11.

A treatment-based classification approach to examination and intervention of lumbar disorders.

Burns SA, Foresman E, Kraycsir SJ, Egan W, Glynn P, Mintken PE, Cleland JA.

Sports Health. 2011 Jul;3(4):362-72.

12.

Mode of action of adjuvants: implications for vaccine safety and design.

Mastelic B, Ahmed S, Egan WM, Del Giudice G, Golding H, Gust I, Neels P, Reed SG, Sheets RL, Siegrist CA, Lambert PH.

Biologicals. 2010 Sep;38(5):594-601. doi: 10.1016/j.biologicals.2010.06.002. Epub 2010 Jul 24.

PMID:
20659806
13.

Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine.

Onions D, Egan W, Jarrett R, Novicki D, Gregersen JP.

Biologicals. 2010 Sep;38(5):544-51. doi: 10.1016/j.biologicals.2010.04.003.

PMID:
20537553
14.

Guidelines on stability evaluation of vaccines.

Dobbelaer R, Pfleiderer M, Haase M, Griffiths E, Knezevic I, Merkle A, Hongzhang Y, Candrian U, Castillo MA, Wood D, Daviaud J, Dellepiane N, Hernandez CA, Lambert S, Shin J-, Knezevic I, Daviaud J, Fournier-Caruna J, Kopp S, Zhou T, Zaffran M, Bektimirov TA, Cooper G, da Silveira SC, Egan W, Medveczky N, Morris T, Griffiths E, Nunez YH, Horiuchi Y, Jivapaisarnpong T, Krause P, Martin J, Southern J, Tyas Utami AR, Jadhav S, Susanti I, Yamaguchi IK, Duchene M, Laschi A, Schofield TL; World Health Organization.

Biologicals. 2009 Nov;37(6):424-34; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.017. Epub 2009 Oct 29. No abstract available.

PMID:
19875304
15.

Basic principles of stability.

Egan W, Schofield T.

Biologicals. 2009 Nov;37(6):379-86; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.012. Epub 2009 Aug 31.

PMID:
19720547
16.

New Cells for New Vaccines II: Focus on Respiratory Virus Diseases.

Egan W, Schild G.

Biologicals. 2008 Nov;36(6):345. doi: 10.1016/j.biologicals.2008.07.003. Epub 2008 Aug 30. No abstract available.

PMID:
18757211
17.

Can we use docking and scoring for hit-to-lead optimization?

Enyedy IJ, Egan WJ.

J Comput Aided Mol Des. 2008 Mar-Apr;22(3-4):161-8. doi: 10.1007/s10822-007-9165-4. Epub 2008 Jan 9.

PMID:
18183356
18.

Potency assays for therapeutic live whole cell cancer vaccines.

Petricciani J, Egan W, Vicari G, Furesz J, Schild G.

Biologicals. 2007 Apr;35(2):107-13. Epub 2006 Aug 1. Review.

PMID:
16882459
19.

In silico prediction of drug safety: despite progress there is abundant room for improvement.

Egan WJ, Zlokarnik G, Grootenhuis PD.

Drug Discov Today Technol. 2004 Dec;1(4):381-7. doi: 10.1016/j.ddtec.2004.11.002.

PMID:
24981618
20.

Forensic discrimination of photocopy and printer toners II. Discriminant analysis applied to infrared reflection-absorption spectroscopy.

Egan WJ, Morgan SL, Bartick EG, Merrill RA, Taylor HJ 3rd.

Anal Bioanal Chem. 2003 Aug;376(8):1279-85. Epub 2003 Jul 9.

PMID:
12910333
21.

Forensic discrimination of photocopy and printer toners. III. Multivariate statistics applied to scanning electron microscopy and pyrolysis gas chromatography/mass spectrometry.

Egan WJ, Galipo RC, Kochanowski BK, Morgan SL, Bartick EG, Miller ML, Ward DC, Mothershead RF 2nd.

Anal Bioanal Chem. 2003 Aug;376(8):1286-97. Epub 2003 Jul 19.

PMID:
12879190
22.

Conformational flexibility of the group B meningococcal polysaccharide in solution.

Henderson TJ, Venable RM, Egan W.

J Am Chem Soc. 2003 Mar 12;125(10):2930-9.

PMID:
12617660
23.

Guiding molecules towards drug-likeness.

Egan WJ, Walters WP, Murcko MA.

Curr Opin Drug Discov Devel. 2002 Jul;5(4):540-9. Review.

PMID:
12197312
24.

Aluminum salts in vaccines--US perspective.

Baylor NW, Egan W, Richman P.

Vaccine. 2002 May 31;20 Suppl 3:S18-23. Review. Erratum in: Vaccine. 2002 Sep 10;20(27-28):3428.

PMID:
12184360
25.

Prediction of intestinal permeability.

Egan WJ, Lauri G.

Adv Drug Deliv Rev. 2002 Mar 31;54(3):273-89. Review.

PMID:
11922948
26.

Computation of the physio-chemical properties and data mining of large molecular collections.

Cheng A, Diller DJ, Dixon SL, Egan WJ, Lauri G, Merz KM Jr.

J Comput Chem. 2002 Jan 15;23(1):172-83.

PMID:
11913384
27.

Review of workshop purposes and goals.

Egan W.

Dev Biol (Basel). 2001;106:3-4. No abstract available.

PMID:
11761244
28.

Postural sway of subjects wearing the U.S. Army chemical protective ensemble after functional activity.

Egan WE, Fisher DP, Gerber LD, Hatler BS, Ernst GP, Hall C, Henderson N.

Aviat Space Environ Med. 2001 Sep;72(9):831-5.

PMID:
11565819
29.

Physico-chemical characterization of polysaccharide vaccines.

Egan W.

Dev Biol (Basel). 2000;103:3-9. Review.

PMID:
11214251
30.

Prediction of drug absorption using multivariate statistics.

Egan WJ, Merz KM Jr, Baldwin JJ.

J Med Chem. 2000 Oct 19;43(21):3867-77.

PMID:
11052792
31.

A statistical-based approach to assessing the fidelity of combinatorial libraries encoded with electrophoric molecular tags. Development and application of tag decode-assisted single bead LC/MS analysis.

Dolle RE, Guo J, O'Brien L, Jin Y, Piznik M, Bowman KJ, Li W, Egan WJ, Cavallaro CL, Roughton AL, Zhao Q, Reader JC, Orlowski M, Jacob-Samuel B, Carroll CD.

J Comb Chem. 2000 Nov-Dec;2(6):716-31.

PMID:
11126300
32.

Outlier detection in multivariate analytical chemical data.

Egan WJ, Morgan SL.

Anal Chem. 1998 Jun 1;70(11):2372-9. doi: 10.1021/ac970763d.

PMID:
21644644
34.
35.

Lot-release criteria, postlicensure quality control, and the Haemophilus influenzae type b conjugate vaccines.

Egan W, Frasch CE, Anthony BF.

JAMA. 1995 Mar 15;273(11):888-9. No abstract available.

PMID:
7869562
36.

Polarimetric detection of land sediment runoff into the ocean using space shuttle imagery.

Egan WG, Sidran M.

Appl Opt. 1994 Dec 1;33(34):8117-9. doi: 10.1364/AO.33.008117.

PMID:
20963038
37.
38.

Synthesis, hydrolytic behavior, and anti-HIV activity of selected acyloxyalkyl esters of trisodium phosphonoformate (foscarnet sodium).

Iyer RP, Boal JH, Phillips LR, Thakker DR, Egan W.

J Pharm Sci. 1994 Sep;83(9):1269-73.

PMID:
7530302
39.
40.

Hepatitis B virus direct repeat sequence: imino proton exchange rates and distance and torsion angle restraints from NMR.

Bishop KD, Blocker FJ, Egan W, James TL.

Biochemistry. 1994 Jan 18;33(2):427-38.

PMID:
8286373
41.

Solution structure of the octamer motif in immunoglobulin genes via restrained molecular dynamics calculations.

Weisz K, Shafer RH, Egan W, James TL.

Biochemistry. 1994 Jan 11;33(1):354-66.

PMID:
8286357
42.

Optical properties of continental haze and cumulus and orographic clouds based on Space Shuttle polarimetric observations.

Egan WG, Israel S, Sidran M, Hindman EE, Johnson WR, Whitehead VS.

Appl Opt. 1993 Nov 20;32(33):6841-52. doi: 10.1364/AO.32.006841.

PMID:
20856538
44.

Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.

Yao GQ, Grill S, Egan W, Cheng YC.

Antimicrob Agents Chemother. 1993 Jul;37(7):1420-5.

45.

Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells.

Gao WY, Storm C, Egan W, Cheng YC.

Mol Pharmacol. 1993 Jan;43(1):45-50.

PMID:
8423768
46.
48.

The octamer motif in immunoglobulin genes: extraction of structural constraints from two-dimensional NMR studies.

Weisz K, Shafer RH, Egan W, James TL.

Biochemistry. 1992 Aug 25;31(33):7477-87.

PMID:
1510934
50.

Conformational states of a TT mismatch from molecular dynamics simulation of duplex d (CGCGATTCGCG).

Venable RM, Widmalm G, Brooks BR, Egan W, Pastor RW.

Biopolymers. 1992 Jul;32(7):783-94.

PMID:
1391631

Supplemental Content

Support Center